Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Canadian Cancer Trials Group
RTOG Foundation, Inc.
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Cancer Trials Ireland
Cancer Trials Ireland